Chief Financial Officer
CurrentActinogen is a biotech company developing novel therapies for Alzheimer’s disease and other potential neurological diseases (ASX:ACW). Currently completing Phase 2a trials of its Xanamem molecule to assess it's impact on Cognitive Impairment in Depression, to be closely followed by Phase 2b trials for Alzheimer's Disease.